Friday, June 24, 2022
HomeCancerProstate Cancer Statistics By Age

Prostate Cancer Statistics By Age

What Are The Statistics For Prostate Cancer

Prostate Cancer Statistics
  • The rate of prostate cancer is higher in African-American men than white men. African-American men are also more than twice as likely to die from prostate cancer. The reasons why are not known. But some risk factors may play a part, such as differences in genes.

  • About 164,690 men in the U.S. will get prostate cancer in 2018. It is the most common cancer in men, not including skin cancer. Nearly 2 out of 3 of these men will be age 65 or older.

  • Prostate cancer is the second leading cause of cancer death in men in the U.S. after lung cancer. About 29,430 men will die of prostate cancer in 2018.

Which Age Groups Have The Highest Incidence Of Prostate Cancer

Prostate cancer incidence increases as men age as many as 60% of men over 65 years of age may be diagnosed with prostate cancer. Prostate cancer is most often diagnosed in men aged 65-74 years median age at diagnosis is 66 years.

However, men as young as 17 years are experiencing an increasing incidence of prostate cancer in much of the world, including the United States, according to data from the Surveillance, Epidemiology, and End Results program and the Institute for Health Metrics and Evaluation Global Burden of Disease database. These younger patients frequently present with more advanced cancer and have worse survival than middle-aged and older men. Worldwide, the incidence of prostate cancer has increased in men ages 15 to 40 years at a steady rate averaging 2% per year since 1990. In the United States, this age group was more than 6 times more likely than older men to have distant disease at diagnosis.

References
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov. 68 :394-424. .

  • American Cancer Society. Cancer Facts & Figures 2021. Available at . Accessed: February 2, 2021.

  • Komyakov BK, Sergeev AV, Fadeev VA, et al. . Urologiia. 2017 Sep. 42-5. .

  • Prostate Cancer Mortality Rate In Canada

    In recent years Prostate cancer mortality rate in Canada significantly decreases due to better health facilities, new treatment options of prostate cancer and measurements taken by Canadian government to reduce the mortality rate of prostate cancer in Canada.According to some surveys and research data current mortality rate is 6.6 per 100,000 Canadian men.

    Read Also: Radiation Dose For Prostate Cancer

    What Are Prostate Cancer Survival Rates By Stage

    Staging evaluation is essential for the planning of treatment for prostate cancer.

    • A basic staging evaluation includes the patient examination, blood tests, and the prostate biopsy including ultrasound images of the prostate.
    • Further testing and calculations may be performed to best estimate a patient’s prognosis and help the doctor and patient decide upon treatment options.

    Prognosis refers to the likelihood that the cancer can be cured by treatment, and what the patient’s life expectancy is likely to be as a consequence of having had a prostate cancer diagnosis.

    If a cancer is cured, your life expectancy is what it would have been had you never been diagnosed with prostate cancer. If the cancer cannot be cured due to it recurring in distant locations as metastases, or recurs either locally or in an area no longer able to be treated in a curative manner, then estimates can be made of what is likely to be your survival based again on group statistics for people who have been in the same situation.

    Nomograms are charts or computer-based tools that use complex math from analysis of many patients’ treatment results.

    The prognosis for prostate cancer varies widely, and depends on many factors, including the age and health of the patient, the stage of the tumor when it was diagnosed, the aggressiveness of the tumor, and the cancer’s responsiveness to treatment, among other factors.

    Screening For Prostate Cancer

    Chart 9 Prostate cancer, incidence rates per 100,000, by ...

    There are no tests available with sufficient accuracy to screen populations of men for early signs of prostate cancer. However, early detection and treatment can significantly improve prostate cancer survival.

    The test most commonly used to aid early detection of prostate cancer is the prostate specific antigen blood test. This is not a diagnostic test as it can only indicate changes in the prostate. If you are concerned about prostate cancer you should talk to your doctor and make an informed choice about whether to have one of the tests designed to find early signs of prostate cancer, in view of the potential risks and benefits.

    There are no proven measures to prevent prostate cancer.

    Read Also: Can Your Prostate Grow Back After Surgery

    Prostate Cancer In Other European Countries

    A general increase in prostate cancer has been witnessed in Western Europe . It is unclear if these figures are secondary to PSA screening or other factors such as diet and low exposure to sunlight . Since mid 1990, an increase of APC between 4 and 5% has been witnessed in Austria, France, and Switzerland. Figures remained stable in other countries such as Netherlands from 1999 to 2008. According to Center et al. , mortality rates decreased in Austria, France, Switzerland, Germany and Netherlands. The main decline was seen in Austria whereas the lowest in Germany and Netherlands . In Southern Europe, an overall increase in prostate cancer was recorded between 1998 and 2007. The largest increase was seen in Croatia followed by Italy, Slovenia, Malta and Spain. Mortality rates were more heterogenous with decline seen in Italy, Malta, Spain and increase in Croatia and Slovenia . An increase in prostate cancer incidence was recorded over the past decade in four out of the five Nordic countries . The most relevant increase was in Denmark . Finland showed stable figures. In terms of mortality, a stable trend was seen in Denmark and Iceland whereas Norway and Sweden experienced a substantial decrease. In Finland, a decrease of 3.1% per annum has been seen since 2000 .

    Prostate Cancer In Central America/caribbean

    Among the Central American countries, Costa Rica leads with an ASR of 53.8 cases per 100,000 people, followed by Mexico and Cuba with 28.9 and 24.3 cases per 100,000 people respectively . Unfortunately, epidemiological data are scarse for those regions. Trends are available only for Costa Rica which showed an annual increase in incidence of 3.8% per annum over the period 19972008. ASR on mortality put Belize at first place with 28.9 cases per 100,000 people followed by Cuba and Mexico with 24.1 and 17.0 cases per 100,000 people for the period 20032010, respectively. Costa Rica stops at 14.8 cases per 100,000 people . The most recent data on Central America published by GLOBOCAN 2020 shows an ASR incidence of 43.8 and mortality of 11.0 cases per 100,000 people . No active screening program are currently in place in Central America. Between 2004 and 2006, in Monterrey a screening program was run, using PSA and DRE screening of 973 men, 40 years of age, showed that only 44% of the men who had an abnormal result underwent prostate biopsy, and 27% of these were diagnosed with prostate cancer, mostly with high grade lesions .

    Don’t Miss: How Do They Do A Biopsy Of Your Prostate

    What Is Prostate Cancer

    Prostate cancer develops when abnormal cells in the prostate gland grow in an uncontrolled way, forming a malignant tumour.

    Prostate cancer is the second most common cancer diagnosed in men in Australia and the third most common cause of cancer death. It is estimated that 18,110 new cases of prostate cancer will be diagnosed in Australia in 2021. One in 6 men will be diagnosed with prostate cancer by the age of 85. It is more common in older men, with over 63% of cases diagnosed in men over 65 years of age.

    Early prostate cancer refers to cancer cells that have grown but do not appear to have spread beyond the prostate.

    There are two stages of advanced prostate cancer:

    • locally advanced prostate cancer where the cancer has spread outside the prostate to nearby parts of the body or glands close to the prostate
    • metastatic prostate cancer where the cancer has spread to distant parts of the body.

    The five year survival rate for prostate cancer is 95%.

    It Was Estimated That In :

    Prostate Cancer Statistics
    • 115,800 Canadian men would be diagnosed with cancer and 44,100 men would die from cancer.
    • 110,000 Canadian women would be diagnosed with cancer and 39,300 women would die from cancer.
    • On average, 617 Canadians would be diagnosed with cancer every day.
    • On average, 228 Canadians would die from cancer every day.
    • Lung, breast, colorectal and prostate cancer are the most commonly diagnosed types of cancer in Canada .
    • These 4 cancers account for about half of all new cancer cases.
    • Prostate cancer accounts for one-fifth of all new cancer cases in men.
    • Lung cancer accounts for 14% of all new cases of cancer.
    • Breast cancer accounts for one-quarter of all new cancer cases in women
    • Colorectal cancer accounts for 12% of all new cancer cases.

    You May Like: Drugs For Metastatic Prostate Cancer

    How Is Prostate Cancer Staged

    Prostate cancer is one of the most common types of cancer that develops in men and is the second leading cause of cancer deaths in American men, behind lung cancer and just ahead of colorectal cancer. The prognosis for prostate cancer, as with any cancer, depends on how advanced the cancer has become, according to established stage designations.

    The prostate gland is a walnut-sized gland present only in men, found in the pelvis below the bladder. The prostate gland wraps around the urethra and lies in front of the rectum. The prostate gland secretes part of the liquid portion of the semen, or seminal fluid, which carries sperm made by the testes. The fluid is essential to reproduction.

    The term to stage a cancer means to describe the evident extent of the cancer in the body at the time that the cancer is first diagnosed.

    • Clinical staging of prostate cancer is based on the pathology results, physical examination, PSA, and if appropriate, radiologic studies.
    • The stage of a cancer helps doctors understand the extent of the cancer and plan cancer treatment.
    • Knowing the overall results of the different treatments of similarly staged prostate cancers can help the doctor and patient make important decisions about choices of treatment to recommend or to accept.

    Cancer Incidence And Mortality Patterns By The 4

    Incidence rates increased with increasing HDI level, ranging from 104.3 and 128.0 per 100,000 in low HDI countries to 335.3 and 267.6 per 100,000 in very high HDI countries for men and women, respectively . Mortality rates are about 2-fold higher in higher HDI countries versus lower HDI countries in men, whereas little variation exists across HDI levels in women .

    • a Incidence excludes basal cell carcinoma, whereas mortality includes all types of nonmelanoma skin cancer.
    • Abbreviation: HDI, Human Development Index.

    Figures and show cancer incidence and mortality ASRs in higher HDI versus lower HDI countries for men and women, respectively, in 2020. For incidence in men , lung cancer ranks first and prostate cancer ranks second in higher HDI countries, and vice versa for lower HDI countries . These cancers were followed by colorectal cancer in higher HDI countries, largely reflecting the substantial contribution by the United States, and lip and oral cavity cancer in lower HDI countries because of the high burden of the disease in India. In women , incidence rates for breast cancer far exceed those of other cancers in both transitioned and transitioning countries, followed by colorectal cancer in transitioned countries and cervical cancer in transitioning countries.

    Figure 7

    Don’t Miss: How Do They Do A Biopsy On Your Prostate

    Prostate Cancer In Asia

    The incidence of prostate cancer in Asian countries has been historically much lower than their Western counterpart, ranging between 4.5 cases per 100,000 persons for South-Central Asia, 10.5 for Eastern Asia and 11.2 for Southeast Asia . Those values could be explained both by a low susceptibility of Asian men to prostate cancer and the lack of a systematic screening program. However, there is evidence that these figures are increasing in several countries . A review by Ha Chung et al., showed a general increase in prostate cancer incidence across China, India, South Korea, Vietnam, Japan, and Singapore . These figures were supported by data from GLOBOCAN 2008 and 2012 . Sim and Cheng noted that in some centres in Japan, the incidence rate rose from 6.3 to 12.7 between 1978 and 1997, while the incidence rates in Singaporean Chinese men increased to 118% within the same period . The lowest incidence reported in Asia was in Shanghai whereas the highest was in the Rizal Province in the Philippines. shows the differences in incidence and mortality across Asia. Studies have also shown that Asian Men living in the United States develop higher risk of prostate cancer than their counterparts living in Asia suggesting that change in lifestyle, and probabaly increased screening, could be the major contributors .

    Cancer Incidence And Death Rates By Sex And World Region

    Facts and Statistics

    Worldwide, the incidence rate for all cancers combined was 19% higher in men than in women in 2020, although rates varied widely across regions. Among men, incidence rates ranged almost 5-fold, from 494.2 per 100,000 in Australia/New Zealand to 100.6 per 100,000 in Western Africa among women, rates varied nearly 4-fold, from 405.2 per 100,000 in Australia/New Zealand to 102.5 per 100,000 in South Central Asia. These variations largely reflect differences in exposure to risk factors and associated cancers and barriers to high-quality cancer prevention and early detection. For example, the highest overall incidence rates in Australia/New Zealand are caused in part by an elevated risk of NMSC because most of the population is light-skinned, and excessive sun exposure is prevalent, in conjunction with increased detection of the disease.

    The gender gap for overall cancer mortality worldwide is twice that for incidence, with death rates 43% higher in men than in women , partly because of differences in the distribution of the cancer types. Death rates per 100,000 persons varied from 165.6 per 100,000 in Eastern Europe to 70.2 per 100,000 in Central America among men and from 118.3 per 100,000 in Melanesia to 63.1 per 100,000 in Central America and South Central Asia among women. Notably, the cumulative risk of dying from cancer among women in 2020 was higher in Eastern Africa than in Northern America , Western Europe , and Australia/New Zealand .

    CANCER SITE

    Lung cancer

    Read Also: Preparation For Radiation Therapy For Prostate Cancer

    Deaths From Prostate Cancer

    Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 41 will die of prostate cancer.

    Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.

    Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

    American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.

    National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.

    Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA . SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

    American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.

    National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.

    Last Revised: January 12, 2021

    Prostate Cancer Epidemiology In Canada

    In Canada, incidence of prostate cancer in men 50 to 59 years of age has increased by 50% in last ten years due to PSA testing.Incidence of loco-regional disease has increased, whereas the incidence of metastatic disease has decreased among Canadian population.

    If we compare the incidence of prostate cancer in Canada with other countries then there is significant increase in prostate cancer incidence in Canada due to PSA testing.Countries having high risk of prostate cancer includes United states, Canada, Sweden and Australia and low risk countries include Indonesia, Korea and Germany.

    Recommended Reading: What Is Stage 3 Prostate Cancer Mean

    What Are The Stages Of Prostate Cancer

    Cancer staging is first described using what is called a TNM system. The “T” refers to a description of the size or extent of the primary, or original, tumor. “N” describes the presence or absence of, and extent of spread of the cancer to lymph nodes that may be nearby or further from the original tumor. “M” describes the presence or absence of metastases — usually distant areas elsewhere in the body other than regional lymph nodes to which the cancer has spread. Cancers with specific TNM characteristics are then grouped into stages, and the stages are then assigned Roman numerals with the numerals used in increasing order as the extent of the cancer being staged increases or the cancer prognosis worsens. Prognosis is finally reflected by considering the patient’s PSA score at presentation as well as their Gleason score in assigning a final stage designation.

    The American Joint Commission on Cancer system for prostate cancer staging is as follows:

    Traditionally, advanced prostate cancer was defined as disease that had widely metastasized beyond the prostate, the surrounding tissue, and the pelvic lymph nodes and was incurable. However, a more contemporary definition includes patients with lower grade disease with an increased risk of progression and/or death from prostate cancer in addition to those with widely metastatic disease.

    The National Cancer Institute and the National Comprehensive Cancer Network guidelines on prostate cancer version 2.2017 indicate the following:

    RELATED ARTICLES

    Most Popular